| |
|
|
A platform to study platelet aggregation and thrombus growth based on dynamic stress
1: School of Electrical and Computer Engineering, RMIT University, Melbourne, VIC 3001, Australia; 2: School of Mechanical and Manufacturing Engineering, The University of New South Wales UNSW, Sydne
We present a microfluidic device that is able to trigger initial recruitment and subsequent aggregation of discoid platelets by mimicking the effects of pathological changes in blood vessel geometry.
|
Sub-classification of colorectal cancer using surface antigen antibody microarray and fluorescence multiplexing
THE UNIVERSITY OF SYDNEY SCHOOL OF MOLECULAR BIOSCIENCES
Colorectal cancer (CRC) is the second most frequent cause of cancer deaths in Australia. Even after resection up to 50% of patients relapse. In an attempt to prevent recurrences chemotherapy is administered to high risk patients. However, as few as 10-20% patients genuinely benefit because the clinical course for individuals with CRC remains difficult to predict, largely due to prognostically heterogeneous groups within same-stage tumour categories.
|
Development of a Fully Integrated Microfluidic Device for Electromodulated Liquid Chromatography with C4D Detection
Sensors and Separations Group, National Centre for Sensor Research, School of Chemical Sciences
Applications for microfluidic technologies in life science are expanding rapidly, and have the potential to impact enormously across a range of
fields, from cell manipulation to separation science. In separation science their small channel dimensions make them ideal for high throughput
separations, reducing sample volumes and solvent consumption.
|
|
|
|
|
|
Post-doctoral position at INRA (France)
INRA
An 18-month post-doctoral position is available at INRA Clermont-Ferrand-Theix (France).The position is opened to both French and foreign applicants.
|
|
|
Engineer Technician, Fayetteville, Arizona, USA
SFC-Fluidics
SFC Fluidics is looking to hire a highly motivated, detail-oriented engineer technician.
oral communication skills . Experience with GMP and GLP desired
|
|
|
Computational Medicinal Chemistry Post-Doc Position, Siena, Italy
University of Siena
NatSynDrugs Is Seeking Candidates For a Computational Medicinal Chemistry Post-Doc Position
|
|
|
Program Development Manager, LasX Industries, MN, USA
LasX Industries
The position of Program Development Manager assumes the lead role for developing production processes for targeted programs, primarily in the micro-fluidics market.
|
|
|
Automation Engineer, Metabolism, Agios Pharmaceuticals, Cambridge, MA, USA
Agios Pharmaceuticals
With new research showing that cancer cells become addicted to using more nutrients than normal cells to promote their rapid growth, there is an unprecedented opportunity to create a new class of oncology therapeutics that target a fundamental and ubiquitous mechanism in cancer cells. The intersection of these two fields of research - cancer and metabolism- represents an important and novel approach to treating cancer.
|
|
|
Senior Scientist, Metabolism
Agios
Agios Pharmaceuticals is seeking a PhD Scientist to join a team that is building and applying a state-of-art approach to investigate the intersection of cancer cell biology and metabolism.
|
|
|
Metabolomics Platform Coordinator, CIBERDEM, Barcelona
CIBERDEM
The Metabolomics Platform is a research facility financed by CIBERDEM, the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders. CIBERDEM is an initiative of the Carlos III Health Institute (Ministry of Science and Innovation, http://www.isciii.es), while the platform is located at the Universitat Rovira i Virgili (Tarragona, Spain).
|
|
|
Senior Fellow, Long Term Research in Metabolomics and Nutrient
PepsiCo
Establish and lead the LTR Pepsico Biology Innovation Lab (PIBL) Metabolomics and Nutrient Physiology research program and team.
|
|
|
|
Single Cell Analysis Summit
28 October 2010 - 29 October 2010
Single Cell Analysis is quickly becoming a large tool in biological investigation and diagnosis in laboratories. Within this conference will be a wide range of topics to cover the entire field, such as label-free analysis, RT-qPCR, microarrays and single cell analysis of genetic disorders.
|
Molecular Diagnostics World Congress
28 October 2010 - 29 October 2010
Molecular Diagnostics is now in its 3rd year and we are pleased to announce that it will be co-located with Microarray World Congress and Lab-on-a-Chip World Congress. The agenda includes topics such as: Molecular Diagnostics & Biomarkers; PGx and Personalized Medicine; Emerging Technologies; Clinical Applications of Molecular Diagnostics; Commercial & Regulatory Perspectives.
|
Microarray World Congress
28 October 2010 - 29 October 2010
Select Biosciences is pleased to announce the 2nd annual Microarray World Congress; our conference dedicated to the latest developments and applications in the rapidly expanding field of microarrays. The Conference is being co-located with Molecular Diagnostics and Lab-on-a-Chip World Congress.
|
|
|
|
|
|
|
|
|
Application of Digital Microfluidics to Point-of-Care Diagnostics
Michael Pollack, Co-Founder, Advanced Liquid Logic, speaking at Lab-on-a-Chip World Congress 2009
|
|
|
A Vesicle-Based Dynamic Lab-on-a-Chip Platform Using Hybrid Integrated Circuit / Microfluidics
David Issadore, Graduate Student, Harvard University, speaking at Lab-on-a-Chip World Congress 2009
|
|
|
A Simple, Rugged Multiwavelength Microflow Cytometer
Peter Howell, Research Chemist, Naval Research Laboratory, speaking at Lab-on-a-Chip World Congress 2009
|
|
|
|
Single Cell Analysis 2010: the New Frontier for 'Omics Market Report
Select Biosciences Ltd
Successful conversion of opportunity to profit requires a detailed understanding of this emerging market. Single-Cell Analysis 2010: the New Frontier for ’Omics explains the key technologies, applications, unmet needs and trends. The 128-page report includes a survey of more than 300 participants, interviews with 5 leading experts, analyses of 25 companies and 16 academic programs and a 5-by-7 quantitative market model of technologies and applications.
|
Multiplexed Diagnostics 2010
Select Biosciences Ltd
The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points.
|
|
|